In a declaration to the media, Challem pointed to two main problems with the study. First, the researchers didn’t use vitamin C, known as ascorbic acid also. Instead, they used an oxidized type of vitamin C referred to as dehydroascorbic acid – – a compound that is not utilized as a dietary health supplement in people. Also, in the experiments with laboratory rodents, the mice were given toxic doses of dehydroascorbic acid. ‘This research and the next headlines [it generated] were a grievous disservice to doctors and patients with malignancy,’ Challem stated in the press statement, adding that ‘significant positive research. Has shown striking benefits from high-dose supplement C in cancer cells and pets – – and in actual humans.Duplex ultrasound should be used to assess both calf vein and superficial venous thrombosis. Anticoagulation with low molecular excess weight heparin or fondaparinux is the favored treatment for calf vein thrombosis and superficial venous thrombosis. Active surveillance can be an option for individuals with calf vein thrombosis who have a high threat of bleeding, a low risk pattern of disease or much less severe symptoms. Topical anti-inflammatory remedies and surveillance can be an option for sufferers with superficial venous thrombosis who’ve a high risk of bleeding or a very small localised thrombosis.. Chemically altered osteoporosis drug may fight malaria A altered osteoporosis drug may be useful in fighting malaria chemically, researchers record in a fresh study. Unlike similar substances tested against other parasitic protozoa, the medication readily crosses in to the red bloodstream cells of malaria-contaminated mice and kills the malaria parasite.